Pharmaceutical composition containing butylphthalide and novel solubilizer
A technology of solubilizer and composition, which is applied in the field of medicine, can solve the problems of large safety hazards in intravenous use, complex prescription composition and preparation process, difficulty in consistent or constant curative effect, etc., so as to improve bioavailability and facilitate dissolution And absorption, resistance to moist heat sterilization effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1-6
[0037] Embodiment 1-6 Butylphthalide injection and preparation method thereof
[0038]
[0039] The preparation method of Examples 1 and 4 is as follows: mix the prescription ingredients except water for injection, and heat to 60°C; then heat the water for injection to the same temperature, and add the water for injection into the above molten liquid under sufficient stirring to obtain Clarify the solution; add activated carbon, keep warm at 60°C for 20 minutes, decarbonize, and filter; add osmotic pressure regulator, mix well, add activated carbon, keep warm, decarbonize, filter; use pH regulator to adjust the pH of the liquid to 4.0-9.0, and fill , sterilized, packaged.
[0040] The preparation methods of Examples 2 and 5 are as follows: (1) Mix all the prescription ingredients, heat to 60°C, and stir thoroughly to obtain a clear solution; add osmotic pressure regulator, mix well, add activated carbon, keep warm, decarbonize, and filter ; Use a pH regulator to adjust the...
Embodiment 7-12
[0042] Embodiment 7-12 Butylphthalide injection and preparation method thereof
[0043]
[0044] The preparation method is as follows: take the prescribed amount of excipients except the main drug butylphthalide and heat to 55°C to melt, add butylphthalide and stir to dissolve; then heat the water for injection to the same temperature, and dissolve the water for injection under sufficient stirring Add to the above molten liquid to obtain a clear solution; add activated carbon, keep warm at 60°C for 30 minutes, decarbonize, filter; add osmotic pressure regulator, and replenish the volume to 1000ml, adjust the pH of the liquid to 4.0-9.0, fill, 121°C Sterilize for 20min, pack.
Embodiment 13
[0045] Embodiment 13 butylphthalide capsules and preparation method thereof
[0046] Take 20g of polyethylene glycol 15-hydroxystearate and heat it to 55°C to melt it, add 40g of butylphthalide, stir; keep the above temperature, add 100g of SyloidFP244, stir well, take it out, cool to room temperature, mix with 80g of mannitol 200SD, 26g of microcrystalline cellulose, mixed evenly, adding an appropriate amount of 2% HPMC aqueous solution, granulated, dried, granulated, added 4g of magnesium stearate, mixed evenly, filled into 0.35g / capsule capsules, and ready.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com